We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A group of indirect purchasers filed a RICO lawsuit against Indian drugmaker Ranbaxy, claiming the company cost them millions of dollars through a criminal enterprise. Read More
According to the complaint, the board pressed sales staff to specifically pressure doctors it identified as key opinion leaders to use their influence to increase prescribing. Read More
Newly unredacted portions of Massachusetts’ lawsuit against Purdue Pharma reveal details of the aggressive sales tactics the lawsuit claims the Oxycontin manufacturer used to increase sales of its opioid products. Read More
As the new Congress looks for ways to address high drug prices, two prominent lawmakers asked Eli Lilly, Novo Nordisk and Sanofi to explain the soaring prices of their insulin products. Read More
In the amended filing, the city claims the Sacklers knew about the risks associated with the drug by the summer of 1999, leading members of the family to conspire to downplay the danger. Read More
Insulin costs nearly doubled from 2012 to 2016, even as usage remained stable, according to a new analysis from the Health Care Costs Institute (HCCI) — a non-profit funded in part by Aetna, Humana, Kaiser Permanente and UnitedHealthcare. Read More
Both New York City and the Massachusetts Attorney General’s office have set their sights on the family behind Purdue Pharma, alleging the Sackler family continued to push Oxycontin despite detailed knowledge of the overdoses, addiction and deaths the product was causing. Read More